Targeting N6-methyladenosine RNA modification combined with immune checkpoint Inhibitors: A new approach for cancer therapy

Targeting N6-methyladenosine RNA modification combined with immune checkpoint Inhibitors: A new approach for cancer therapy

Immune checkpoint inhibitors (ICIs) have revolutionized cancer immunotherapy by restoring the host antitumor immune response. Since 2011, various ICIs have been approved for the treatment of cancers, which has led to unprecedented prolongation of the survival time for some patients. Although ICIs ha...

Full description

Bibliographic Details
Main Authors: Weiwei Liu, Chaoqun Liu, Hui Wang, Lijun Xu, Jueyu Zhou, Sihua Li, Yu Cheng, Rui Zhou, Liang Zhao
Format: Article
Language:English
Published: Elsevier 2022-01-01
Series:Computational and Structural Biotechnology Journal
Subjects:
ICB
M6A modification
Cancer immunotherapy
m6A regulators
Online Access:http://www.sciencedirect.com/science/article/pii/S2001037022004202

Internet

http://www.sciencedirect.com/science/article/pii/S2001037022004202

Similar Items